Total Assets Summary of Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited's latest annual total assets in 2023 was 63.6 Billion CNY , down -0.72% from previous year.
Sino Biopharmaceutical Limited's latest quarterly total assets in 2024 Q2 was 66.7 Billion CNY , down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported annual total assets of 64.06 Billion CNY in 2022, up 5.82% from previous year.
Sino Biopharmaceutical Limited reported annual total assets of 60.54 Billion CNY in 2021, up 28.24% from previous year.
Sino Biopharmaceutical Limited reported quarterly total assets of 66.7 Billion CNY for 2024 Q1, up 4.87% from previous quarter.
Sino Biopharmaceutical Limited reported quarterly total assets of 63.6 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Total Assets of Sino Biopharmaceutical Limited (2023 - 1999)

Year	Total Assets	Total Assets Growth
2023	63.6 Billion CNY	-0.72%
2022	64.06 Billion CNY	5.82%
2021	60.54 Billion CNY	28.24%
2020	47.21 Billion CNY	-19.02%
2019	58.29 Billion CNY	17.11%
2018	49.78 Billion CNY	137.78%
2017	20.93 Billion CNY	13.83%
2016	18.39 Billion CNY	33.25%
2015	13.8 Billion CNY	21.86%
2014	11.32 Billion CNY	45.4%
2013	7.78 Billion CNY	23.79%
2012	6.29 Billion CNY	23.5%
2011	5.09 Billion CNY	6.37%
2010	4.79 Billion CNY	44.46%
2009	3.31 Billion CNY	15.26%
2008	2.87 Billion CNY	18.31%
2007	2.43 Billion CNY	9.48%
2006	2.22 Billion CNY	-0.3%
2005	2.22 Billion CNY	127.72%
2004	978.33 Million CNY	24.67%
2003	784.74 Million CNY	24.49%
2002	630.36 Million CNY	37.14%
2001	459.65 Million CNY	13.53%
2000	404.88 Million CNY	40.79%
1999	287.56 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	66.7 Billion CNY	0.0%
2024 Q1	66.7 Billion CNY	4.87%
2023 Q4	63.6 Billion CNY	0.0%
2023 FY	63.6 Billion CNY	-0.72%
2023 Q3	63.6 Billion CNY	-3.1%
2023 Q2	65.64 Billion CNY	0.0%
2023 Q1	65.64 Billion CNY	2.46%
2022 Q2	64.93 Billion CNY	0.0%
2022 Q4	64.06 Billion CNY	0.0%
2022 FY	64.06 Billion CNY	5.82%
2022 Q3	64.06 Billion CNY	-1.34%
2022 Q1	64.93 Billion CNY	7.25%
2021 FY	60.54 Billion CNY	28.24%
2021 Q1	49.15 Billion CNY	4.11%
2021 Q2	56.2 Billion CNY	14.35%
2021 Q3	60.54 Billion CNY	7.72%
2021 Q4	60.54 Billion CNY	0.0%
2020 Q1	66.64 Billion CNY	14.31%
2020 Q2	68.34 Billion CNY	2.56%
2020 Q3	66.2 Billion CNY	-3.14%
2020 Q4	47.21 Billion CNY	-28.69%
2020 FY	47.21 Billion CNY	-19.02%
2019 Q2	53.47 Billion CNY	3.95%
2019 Q1	51.43 Billion CNY	3.33%
2019 Q4	58.29 Billion CNY	8.42%
2019 FY	58.29 Billion CNY	17.11%
2019 Q3	53.77 Billion CNY	0.57%
2018 FY	49.78 Billion CNY	137.78%
2018 Q2	34.98 Billion CNY	1.41%
2018 Q1	34.49 Billion CNY	64.79%
2018 Q4	49.78 Billion CNY	33.48%
2018 Q3	37.29 Billion CNY	6.6%
2017 Q3	20.58 Billion CNY	4.98%
2017 Q4	20.93 Billion CNY	1.71%
2017 Q2	19.6 Billion CNY	-1.49%
2017 Q1	19.9 Billion CNY	8.22%
2017 FY	20.93 Billion CNY	13.83%
2016 FY	18.39 Billion CNY	33.25%
2016 Q3	17.7 Billion CNY	12.86%
2016 Q4	18.39 Billion CNY	3.86%
2016 Q1	15.12 Billion CNY	9.55%
2016 Q2	15.69 Billion CNY	3.77%
2015 FY	13.8 Billion CNY	21.86%
2015 Q4	13.8 Billion CNY	-3.83%
2015 Q2	13.46 Billion CNY	8.85%
2015 Q1	12.37 Billion CNY	9.22%
2015 Q3	14.35 Billion CNY	6.58%
2014 Q4	11.32 Billion CNY	5.06%
2014 Q2	10.42 Billion CNY	18.11%
2014 Q3	10.78 Billion CNY	3.44%
2014 FY	11.32 Billion CNY	45.4%
2014 Q1	8.82 Billion CNY	13.28%
2013 Q4	7.78 Billion CNY	1.7%
2013 FY	7.78 Billion CNY	23.79%
2013 Q3	7.65 Billion CNY	6.19%
2013 Q2	7.21 Billion CNY	4.98%
2013 Q1	6.87 Billion CNY	9.19%
2012 Q3	6.44 Billion CNY	8.95%
2012 Q4	6.29 Billion CNY	-2.32%
2012 FY	6.29 Billion CNY	23.5%
2012 Q2	5.91 Billion CNY	0.0%
2011 Q4	5.09 Billion CNY	-3.36%
2011 Q1	4.93 Billion CNY	0.0%
2011 FY	5.09 Billion CNY	6.37%
2011 Q2	5.32 Billion CNY	7.87%
2011 Q3	5.27 Billion CNY	-0.98%
2010 Q2	4.65 Billion CNY	0.0%
2010 FY	4.79 Billion CNY	44.46%
2009 Q4	3.31 Billion CNY	0.0%
2009 FY	3.31 Billion CNY	15.26%
2008 FY	2.87 Billion CNY	18.31%
2007 FY	2.43 Billion CNY	9.48%
2006 FY	2.22 Billion CNY	-0.3%
2005 FY	2.22 Billion CNY	127.72%
2004 FY	978.33 Million CNY	24.67%
2003 FY	784.74 Million CNY	24.49%
2002 FY	630.36 Million CNY	37.14%
2001 FY	459.65 Million CNY	13.53%
2000 FY	404.88 Million CNY	40.79%
1999 FY	287.56 Million CNY	0.0%

Peer Total Assets Comparison of Sino Biopharmaceutical Limited

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-15413.673%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	-465.506%

Global Stocks Search

Sino Biopharmaceutical Limited (1177.HK)

Total Assets Summary of Sino Biopharmaceutical Limited

Annual Total Assets Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Total Assets of Sino Biopharmaceutical Limited (2023 - 1999)

Peer Total Assets Comparison of Sino Biopharmaceutical Limited